License and Collaboration Agreements - Additional Information (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Jun. 30, 2022	Mar. 31, 2023	Mar. 31, 2022
License And Collaboration Agreements [Line Items]
Research and development costs		$ 52,096	$ 24,536
Harbour License Agreement [Member]
License And Collaboration Agreements [Line Items]
Upfront license fee		25,000
Harbour BioMed US Inc. [Member] | Harbour License Agreement [Member]
License And Collaboration Agreements [Line Items]
Upfront license fee		25,000
Harbour BioMed US Inc. [Member] | Maximum | Harbour License Agreement [Member] | Achievement Based [Member]
License And Collaboration Agreements [Line Items]
Aggregate amount of milestone payment		148,000
Harbour BioMed US Inc. [Member] | Maximum | Harbour License Agreement [Member] | Sales Based [Member]
License And Collaboration Agreements [Line Items]
Aggregate amount of milestone payment		415,000
Pearl - Taiho
License And Collaboration Agreements [Line Items]
Percentage of profits from potential sales	50.00%
Research and development expense related to share of costs		4,700
Accrued expenses and other current liabilities		2,700
Research and development costs		1,000
Adimab
License And Collaboration Agreements [Line Items]
Research and development costs			$ 500
MIT
License And Collaboration Agreements [Line Items]
Research and development costs		$ 200